Salarius Pharmaceuticals Inc (SLRX)
0.4631
-0.03
(-5.47%)
USD |
NASDAQ |
May 20, 16:00
0.4631
0.00 (0.00%)
After-Hours: 20:00
Salarius Pharmaceuticals Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2019 | 54.91% |
| December 31, 2018 | 54.05% |
| September 30, 2018 | 63.37% |
| June 30, 2018 | 26.70% |
| March 31, 2018 | 53.00% |
| December 31, 2017 | 52.85% |
| Date | Value |
|---|---|
| September 30, 2017 | 64.03% |
| June 30, 2017 | 56.69% |
| March 31, 2017 | 67.39% |
| December 31, 2016 | 55.27% |
| September 30, 2016 | 63.09% |
| June 30, 2016 | 1.56% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Masimo Corp | 49.05% |
| Esperion Therapeutics Inc | 92.69% |
| SINTX Technologies Inc | 27.83% |
| Flora Growth Corp | 19.42% |
| NovaBay Pharmaceuticals Inc | 68.19% |